Volibo R 0.3/1 mg Tablet (10 Tab)

About Avizox CV 500mg/125mg Tablet

Avizox CV 500mg/125mg Tablet is a broad-spectrum antibiotic combination used to treat a variety of bacterial infections affecting the respiratory tract, urinary tract, ear, nose, throat, skin, and soft tissues. It helps eliminate infection-causing bacteria and prevents them from multiplying further.

Key Ingredients

• Amoxicillin (500 mg): A penicillin-type antibiotic that kills bacteria by preventing the formation of their protective cell wall.
• Clavulanic Acid (125 mg): A beta-lactamase inhibitor that prevents bacteria from developing resistance against amoxicillin, thereby enhancing its effectiveness.

Key Benefits of Avizox CV 500mg/125mg Tablet

• Effectively treats respiratory infections like bronchitis, pneumonia, and sinusitis.
• Useful in urinary tract infections (UTIs) and skin infections.
• Helps cure dental, ear, and soft tissue infections.
• Provides dual protection by combining antibiotic action with resistance prevention.

Directions for Use

• Take Avizox CV 500mg/125mg Tablet as prescribed by your doctor.
• Swallow it whole with water, preferably after meals to avoid stomach upset.
• Complete the full course even if you feel better to prevent antibiotic resistance.

Possible Side Effects

• Nausea, vomiting, or diarrhea
• Stomach pain or indigestion
• Mild skin rash or itching
• Rarely, allergic reactions or liver enzyme changes

Safety Advice

• Inform your doctor if you have kidney, liver, or gastrointestinal disorders.
• Avoid alcohol during treatment, as it may worsen side effects.
• Use cautiously in pregnancy or breastfeeding, under medical supervision.
• Do not use for viral infections such as cold or flu.

Storage Instructions
Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Product Variants & Keywords
Avizox CV 500mg/125mg Tablet, Amoxicillin + Clavulanic Acid Tablet, Broad-Spectrum Antibiotic, Bacterial Infection Treatment, Respiratory and Urinary Infection Medicine.